Back to Wealth Enhancement Advisory Services, LLC Wealth Enhancement Advisory Services, LLC

ABBVABBV

Showing 9 of 29 quarters

Position history for Wealth Enhancement Advisory Services, LLCWealth Enhancement Advisory Services, LLC's holdings in AbbVie Inc.

Yes. Wealth Enhancement Advisory Services holds 763,184 shares of ABBV (AbbVie), worth $180.2M, as of its Q3 2026 13F filing. It increased the position by 186,641 shares (+32.4%) from Q2 2026. Wealth Enhancement Advisory Services has held ABBV since Q1 2023, across 15 quarterly 13F filings. ABBV is 0.3% of Wealth Enhancement Advisory Services' reported 13F portfolio.

Current Value

$180.2M

Current Shares

763,184

Total Value Change

+$70.4M

Total Shares Change

+206,889

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
763,184
+32.4%
$180.2M0.3%$259.99
47
2026-Q2
Increased
576,543
+6.7%
$117.4M0.2%$248.34
38
2026-Q1
Decreased
540,541
-15.1%
$92.7M0.2%$212.87
0
2025-Q4
Increased
636,710
+11.7%
$143M0.2%$221.85
40
2025-Q3
Increased
569,990
+2.8%
$132.6M0.2%$223.20
37
2025-Q2
Increased
554,650
+3.4%
$105M0.2%$177.40
37
2025-Q1
Increased
536,450
+2.3%
$112.4M0.2%$198.41
37
2024-Q4
Decreased
524,365
-5.7%
$93.2M0.2%$166.71
0
2024-Q3
Increased
556,295
+23.1%
$109.9M0.2%$183.80
43

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used